DRUG
Income statement / Annual
Last year (2025), Bright Minds Biosciences Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Bright Minds Biosciences Inc's net income was -$12.23 M.
See Bright Minds Biosciences Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
09/30/2025 |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$11.08 M
|
$1.18 M
|
$5.00 M
|
$12.18 M
|
$6.31 M
|
$354.85 K
|
$126.03 K
|
| General & Administrative Expenses |
$2.14 M
|
$1.40 M
|
$2.08 M
|
$2.00 M
|
$1.46 M
|
$104.89 K
|
$110.12 K
|
| Selling & Marketing Expenses |
$429.66 K
|
$41.60 K
|
$119.42 K
|
$551.86 K
|
$852.15 K
|
$9.62 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.57 M
|
$1.45 M
|
$2.20 M
|
$2.55 M
|
$2.31 M
|
$114.51 K
|
$110.12 K
|
| Other Expenses |
$287.65 K
|
$197.19 K
|
$186.65 K
|
$243.08 K
|
$0.00
|
$5.45 K
|
$0.00
|
| Operating Expenses |
$13.94 M
|
$2.82 M
|
$7.39 M
|
$14.98 M
|
$8.62 M
|
$474.81 K
|
$236.15 K
|
| Cost And Expenses |
$13.94 M
|
$2.82 M
|
$7.39 M
|
$14.98 M
|
$8.62 M
|
$474.81 K
|
$236.15 K
|
| Interest Income |
$1.52 M
|
$30.13 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$76.87 K
|
$73.36 K
|
$72.45 K
|
$6.04 K
|
$8.62 M
|
$474.93 K
|
$236.15 K
|
| EBITDA |
-$13.86 M |
-$2.75 M |
-$7.31 M |
-$14.97 M |
$0.00 |
$0.00 |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.71 M
|
$20.82 K
|
$14.19 K
|
$10.15 K
|
-$27.64 K
|
-$5.45 K
|
$0.00
|
| Income Before Tax |
-$12.23 M
|
-$2.80 M
|
-$7.37 M
|
-$14.96 M
|
-$8.65 M
|
-$480.38 K
|
-$236.15 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$12.23 M
|
-$2.80 M
|
-$7.37 M
|
-$14.96 M
|
-$8.65 M
|
-$480.38 K
|
-$236.15 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.78 |
-0.65 |
-1.98 |
-6.15 |
-4.74 |
-0.38 |
-0.0615 |
| EPS Diluted |
-1.78 |
-0.65 |
-1.98 |
-6.15 |
-4.74 |
-0.38 |
-0.0615 |
| Weighted Average Shares Out |
$6.88 M
|
$4.31 M
|
$3.72 M
|
$2.47 M
|
$1.79 M
|
$1.28 M
|
$1.28 M
|
| Weighted Average Shares Out Diluted |
$6.88 M
|
$4.31 M
|
$3.72 M
|
$2.47 M
|
$1.79 M
|
$1.28 M
|
$1.28 M
|
| Link |
|
|
|
|
|
|
|
